Immuneering Corp (IMRX)
2.005
+0.16
(+8.97%)
USD |
NASDAQ |
Dec 20, 16:00
2.01
0.00 (0.00%)
After-Hours: 20:00
Immuneering Shareholders Equity (Quarterly): 57.72M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 178.82M |
| PTC Therapeutics Inc | -1.054B |
| AN2 Therapeutics Inc | 87.67M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.56M |
| Total Liabilities (Quarterly) | 10.84M |